MFA
Mayflower Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
2,813
-91
| -3% | -$36.9K | 0.16% | 136 |
|
|
2025
Q1 | $1.45M | Sell |
2,904
-107
| -4% | -$53.2K | 0.22% | 109 |
|
|
2024
Q4 | $1.57M | Buy |
3,011
+17
| +0.6% | +$8.84K | 0.23% | 102 |
|
|
2024
Q3 | $1.85M | Buy |
2,994
+14
| +0.5% | +$8.66K | 0.28% | 84 |
|
|
2024
Q2 | $1.65M | Buy |
2,980
+105
| +4% | +$58.1K | 0.27% | 84 |
|
|
2024
Q1 | $1.67M | Buy |
2,875
+53
| +2% | +$30.8K | 0.28% | 84 |
|
|
2023
Q4 | $1.5M | Sell |
2,822
-341
| -11% | -$181K | 0.21% | 99 |
|
|
2023
Q3 | $1.6M | Buy |
3,163
+43
| +1% | +$21.8K | 0.24% | 89 |
|
|
2023
Q2 | $1.63M | Sell |
3,120
-24
| -0.8% | -$12.5K | 0.21% | 95 |
|
|
2023
Q1 | $1.81M | Buy |
3,144
+204
| +7% | +$118K | 0.24% | 86 |
|
|
2022
Q4 | $1.62M | Buy |
2,940
+171
| +6% | +$94.2K | 0.22% | 89 |
|
|
2022
Q3 | $1.4M | Sell |
2,769
-301
| -10% | -$153K | 0.23% | 85 |
|
|
2022
Q2 | $1.67M | Sell |
3,070
-8
| -0.3% | -$4.35K | 0.26% | 80 |
|
|
2022
Q1 | $1.82M | Sell |
3,078
-178
| -5% | -$105K | 0.24% | 75 |
|
|
2021
Q4 | $2.17M | Buy |
3,256
+8
| +0.2% | +$5.34K | 0.29% | 65 |
|
|
2021
Q3 | $1.92M | Buy |
3,248
+208
| +7% | +$123K | 0.26% | 71 |
|
|
2021
Q2 | $1.53M | Sell |
3,040
-354
| -10% | -$179K | 0.21% | 75 |
|
|
2021
Q1 | $1.55M | Buy |
3,394
+299
| +10% | +$136K | 0.23% | 74 |
|
|
2020
Q4 | $1.44M | Buy |
+3,095
| New | +$1.44M | 0.25% | 66 |
|